References
- American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Clinical management guidelines for obstetrician–gynecologist. Number 43, May 2003. Management of preterm labor. Obstet Gynecol 2003; 101: 1039–1047
- Papiernik E. Double blind study of an agent to prevent pre-term delivery among women at increased risk. Schering ed. Series IV 1970; 65–68
- Johnson J W, Austin K L, Jones G S, Davis G H, King T M. Efficacy of 17α-hydroxyprogesterone caproate in the prevention of premature labor. N Engl J Med 1975; 293: 675–680
- Yemini M, Borenstein R, Dreazen E, Apelman Z, Mogilner B M, Kessler I, Lancet M. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 1985; 151: 574–577
- Hartikainen-Sorri A L, Kauppila A, Tuimala R. Inefficacy of 17α hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy. Obstet Gynecol 1980; 56: 692–695
- Hauth J C, Gilstrap L C, III, Brekken A L, Hauth J M. The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population. Am J Obstet Gynecol 1983; 146: 187–190
- Goldstein P, Berrier J, Rosen S, Sacks H S, Chalmers T C. A meta-analysis of randomized controls trials of progestational agents in pregnancy. Br J Obstet Gynaecol 1989; 96: 265–274
- Meis P J, Klevanoff M, Thom E, Dombrowski M P, Sibai B, Moawad A H, Spong C Y, Hauth J C, Miodovnik M, Varner M W, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348: 2379–2385
- Sanchez-Ramos L, Kaunitz A M, Delke I. Progestational agents to prevent preterm birth: A meta-analysis of randomized controlled trials. Obstet Gynecol 2005; 105: 273–279
- American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 291. Use of progesterone to reduce preterm birth. Obstet Gynecol 2003; 102: 1115–1116
- Koontz G. Does gestational age at randomization affect the efficacy of alpha hydroxyprogesterone caproate (17-OHCP) in preventing recurrent preterm delivery?. Am J Obstet Gynecol 2005; 193: S55
- da Fonseca E B, Bittar R E, Carvalho M H, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double blind study. Am J Obstet Gynecol 2003; 1884: 419–424
- Iams J D, Goldenberg R L, Mercer B M, Moawad A, Thom E, Meis P J, McNellis D, Caritis S N, Miodovnik M, Menard M K, et al. The preterm prediction study: Recurrence risk of spontaneous preterm birth. National Institute of Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1998; 178: 1035–1040
- Adams M M, Elam-Evans L D, Wilson H G, Gilberts D A. Rates of and factors associated with recurrence of preterm delivery. JAMA 2000; 283: 1591–1596
- Meis P J, Klebanoff M, Dombrowski M P, Sibai B M, Leindecker S, Moawad A H, Northen A, Iams J D, Varner M W, Caritis S N, et al. Does progesterone treatment influence risk factors for recurrent preterm delivery?. Obstet Gynecol 2005; 106: 557–661